Few pharmacoeconomic data to support use of lipid formulations of amphotericin B

Drugs and Therapy Perspectives

Volumn 7, Issue 5, 1996, Pages 14-16

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; LIPID; LIPOSOME; NYSTATIN;

BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRYPTOCOCCUS; DRUG FORMULATION; HUMAN; MENINGITIS; MYCOSIS; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; OROPHARYNX; PHARMACOECONOMICS; SHORT SURVEY; SYSTEMIC MYCOSIS;

EID: 0029876470     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-199607050-00005     Document Type: Short Survey

References (11)

1. Tollemar J, Ringdén O. Lipid formulations of amphotericin B: less toxicity but at what economic cost? Drug Saf 1995 Oct; 13(4): 207-18
2. Janknegt R, de Marie S, Bakker-Woudenberg IAJM, et al. Liposomal and lipid formulations of amphotericin B. Clin Pharmacokinet 1992 Oct; 23(4): 279-91
3. British National Formulary No. 30. London: The Pharmaceutical Press, 1995 Sep; 256-7
4. 1995 Physicians GenRx. St Louis, Missouri: Mosby-Year Book, Inc., 1995; 103-5
5. Fungizone intravenous. ABPI data sheet compendium, 1995/96. London: Datapharma Publications Ltd, 1995
6. Tollemar J, Andersson S, Ringden O, et al. A retrospective clinical comparison between antifungal treatment with liposomal amphotericin-B (AmBisome) and conventional amphotericin-B in transplant recipients. Mycoses 1992 Sep/Oct; 35: 215-20
7. Persson U, Tennvall GR, Andersson S. Cost-effectiveness analysis of treatment with liposomal amphotericin B versus conventional amphotericin B in organ or bone marrow transplant recipients with systemic mycoses. PharmacoEconomics 1992 Dec; 2(6): 500-8
8. Tollemar J, Höckerstedt K, Ericzon B-G, et al. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients: a randomized, placebo-controlled study. Transplantation 1995 Jan 15; 59: 45-50
9. Stewart A, Powles R, Hewetson M, et al. Costs of antifungal prophylaxis after bone marrow transplantation. A model comparing oral fluconazole, liposomal amphotericin and oral polyenes as prophylaxis against oropharyngeal infections. PharmacoEconomics 1995 Oct; 8(4): 350-61
10. Buxton MJ, Dubois DJ, Turner RR, et al. Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. J Infect 1991; 23: 17-31
11. American Hospital Formulary Service Drug Information. Bethesda: American Society of Hospital Pharmacists, 1995: 72-6